S-S2
BMT Tandem Luncheon Symposium: Current Status of Stem Cell Transplantation for Acute Lymphoblastic Leukemia

Track: BMT Tandem "Scientific" Meeting
Thursday, February 27, 2014: 12:30 PM-1:30 PM
Texas B+D (Gaylord Texan)
Chair:
Jacob M. Rowe, MD

Disclosures:
J. M. Rowe, Sanofi-Aventis, Amgen: Consulting Fees

Summary:

Supported by an independent educational grant from Amgen, Inc.

Role of MRD in Predicting Outcomes of Transplant in ALL
Robert Negrin, MD, Stanford University Medical Center

Audio File Recorded Presentation
Transplant in Ph+ Acute Lymphoblastic Leukemia: When, Why, and How?
Jacob M. Rowe, MD, Rambam Medical Center

New Approaches for Improving Transplant Outcomes in ALL Patients with MRD
Mark R. Litzow, MD, Mayo Clinic

Audio File Recorded Presentation
See more of: BMT Tandem "Scientific" Meeting
<< Previous Session | Next Session >>